ROBERT G PEREZ

Allopathic & Osteopathic Physicians|Surgery DALY CITY, CA NPI 1699866061

General Payments — all program years on this page

$1,144.36

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 42
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $283.76 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $283.7618

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Celgene Corporation $138.0311
Acerta Pharma LLC $43.612
CALLIDITAS THERAPEUTICS US INC. $39.672
Ardelyx, Inc. $24.371
Mallinckrodt Hospital Products Inc. $19.511
Amgen Inc. $18.571

By program year

Program yearAmountRecords
2018 $108.971
2019 $26.271
2020 $336.997
2022 $79.752
2023 $308.6213
2024 $283.7618

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101166806 Celgene Corporation $10.25 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101166808 Celgene Corporation $8.25 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101166812 Celgene Corporation $9.73 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101166816 Celgene Corporation $11.55 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101166818 Celgene Corporation $15.15 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101166822 Celgene Corporation $9.40 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101166824 Celgene Corporation $12.46 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101166826 Celgene Corporation $14.35 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101166830 Celgene Corporation $14.66 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101166844 Celgene Corporation $18.97 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101166848 Celgene Corporation $13.26 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104469188 AstraZeneca Pharmaceuticals LP $17.98 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105399511 AstraZeneca Pharmaceuticals LP $25.63 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117653260 Amgen Inc. $18.57 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141511631 CALLIDITAS THERAPEUTICS US INC. $20.49 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141528449 CALLIDITAS THERAPEUTICS US INC. $19.18 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145119606 Mallinckrodt Hospital Products Inc. $19.51 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146700746 Ardelyx, Inc. $24.37 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.